For the last 18 years The Bell-Mason Group has been preeminent in providing advisory services to large corporations and emerging companies seeking to accelerate growth and innovation through venturing. Here is a sample list of our clients: Philips Electronics, Eastman Chemical Company, Mitsubishi International, ChevronTexaco, C N A Insurance, W.W.Grainger, R.R. Donnelley, Deluxe, Praxair, Boeing, Michelin, TRW, Marriott, Amgen, Nokia, Citigroup...

With its veteran practitioners in corporate innovation, corporate venture capital, corporate incubation and independent venture development, the firm also makes available the best of breed tools it has created and methodically perfected through the years. The Bell-Mason Group provides frameworks, diagnostics, tools and templates which can be quickly integrated into newly created or existing corporate venturing processes.

CABOT CORPORATION Greg Romney General Manager, Energy Materials . . . . . . . . . . . . . . . . . "During my time leading ChevronTexaco's new venture related to fuel cell technology, the diagnostic allowed us to calibrate our new venture against meaningful best practices…and chart a path forward. It also was essential in giving us a meaningful language for dialog with our parent corporation...the diagnostic is an essential tool for new venture leaders and their corporate investors."

PRICEWATERHOUSE COOPERS Tracy Lefteroff Global Managing Partner, Private Equity & Venture Capital & Life Sciences Industry Services Center . . . . . . . . . . . . . . . . . . "When it was first introduced, the BMD was a revolutionary means of evaluating the strengths and weaknesses of early stage ventures, across technologies and industry sectors. The BMD is every bit as valuable today as it was when we first used it."

EASTMAN CHEMICAL Roger Mowen Former Senior Vice President, Developing Businesses & Corporate Strategy, and Executive Team Member Reporting Directly to the CEO of Eastman Chemical Company . . . . . . . . . . . . . . . . . "Through extensive experience and time-tested tool kits, the Bell-Mason Group quickly, thoroughly, and accurately diagnosed the critical issues facing one of our developing businesses. They prescribed a realistic path forward with tangible, incremental milestones that we could monitor."

NANYANG VENTURES P/L Christopher C. Golis Executive Chairman . . . . . . . . . . . . . . . . "The Bell-Mason has proven to be an excellent screening tool. The typical VC survival rate for early stage investing is around 50% -- ours is over 90%."